These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19285890)

  • 1. Intravitreal bevacizumab for idiopathic choroidal neovascularization.
    Cakir M; Cekiç O; Yilmaz OF
    J AAPOS; 2009 Jun; 13(3):296-8. PubMed ID: 19285890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravitreal Bevacizumab injections in a child with choroidal neovascularization--case report].
    Krzyzanowska-Berkowska P; Barć A; Oficjalska J
    Klin Oczna; 2011; 113(1-3):60-3. PubMed ID: 21853954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease.
    Cakir M; Cekiç O; Yilmaz OF
    J AAPOS; 2009 Feb; 13(1):94-6. PubMed ID: 19101187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization.
    Inoue M; Kadonosono K; Watanabe Y; Sato S; Kobayashi S; Yamane S; Ito R; Arakawa A
    Retina; 2010 May; 30(5):733-8. PubMed ID: 20168271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic effects of intravitreal bevacizumab in a patient with recalcitrant idiopathic polypoidal choroidal vasculopathy.
    Ghajarnia M; Kurup S; Eller A
    Semin Ophthalmol; 2007; 22(2):127-31. PubMed ID: 17564935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab for choroidal neovascularization in toxoplasmosis.
    Guthoff R; Goebel W
    Acta Ophthalmol; 2009 Sep; 87(6):688-90. PubMed ID: 18631326
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravitreal bevacizumab in choroidal neovascularization associated with congenital choroidal and optic nerve coloboma in children: long-term improvement in visual acuity.
    Naithani P; Vashisht N; Mandal S; Sankaran P; Garg S
    J AAPOS; 2010 Jun; 14(3):288-90. PubMed ID: 20603066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Furino C; Boscia F; Recchimurzo N; Besozzi G; Cardascia N; Sborgia L; Niro A; Sborgia C
    Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab for choroidal neovascularization related to inflammatory diseases.
    Kramer M; Axer-Siegel R; Jaouni T; Reich E; Hemo I; Priel E; Averbukh E; Ehrlich R; Chowers I; Weinberger D; Amer R
    Retina; 2010 Jun; 30(6):938-44. PubMed ID: 20168273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization.
    Mandal S; Garg S; Venkatesh P; Mithal C; Vohra R; Mehrotra A
    Arch Ophthalmol; 2007 Nov; 125(11):1487-92. PubMed ID: 17998509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab.
    Lucas RS; McKee HD; Lee LR
    Ophthalmology; 2007 Feb; 114(2):400; author reply 400-1. PubMed ID: 17270701
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
    Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
    Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravitreal bevacizumab treatment for choroidal neovascularization in Best's disease].
    Perol J; Wolff B; Sahel JA; Le Mer Y
    J Fr Ophtalmol; 2011 May; 34(5):281-6. PubMed ID: 21507509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular functional changes evaluated with MP-1 microperimetry after intravitreal bevacizumab for subfoveal myopic choroidal neovascularization: one-year results.
    Scupola A; Tiberti AC; Sasso P; Savastano MC; Mastrocola A; Marangoni D; Minnella AM; Falsini B; Balestrazzi E
    Retina; 2010 May; 30(5):739-47. PubMed ID: 20038860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma.
    De Benedetto U; Battaglia Parodi M; Knutsson KA; Librando A; Bandello F; Lanzetta P; Iacono P
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):550-2. PubMed ID: 22554238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab for idiopathic choroidal neovascularization after previous injection with posterior subtenon triamcinolone.
    Gomi F; Nishida K; Oshima Y; Sakaguchi H; Sawa M; Tsujikawa M; Tano Y
    Am J Ophthalmol; 2007 Mar; 143(3):507-10. PubMed ID: 17317397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential therapy with intravitreal bevacizumab and photodynamic therapy for idiopathic polypoidal choroidal vasculopathy.
    Pai SA; Shetty R
    Acta Ophthalmol; 2009 Nov; 87(7):806-7. PubMed ID: 18721250
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane.
    Shanmugam MP; Mythri HM; Shetty NS
    Indian J Ophthalmol; 2007; 55(6):490-1. PubMed ID: 17951923
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
    Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.